0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Postmarketing Surveillance and Black Box Warnings

Anthony K. Wutoh, PhD, RPh; Rita D. Wutoh, MD, MPH
JAMA. 2002;288(8):955-959. doi:10.1001/jama.288.8.955.
Text Size: A A A
Published online

Extract

To the Editor: Although Dr Lasser and colleagues1 made several general conclusions about the drug approval process and length of time that elapses between initial FDA approval and black box warnings regarding serious ADRs, the situation is more complex. We believe that the time between initial approval and appearance of black box warnings must be assessed on an individual basis. For example, with ganciclovir, the warning was "oral form not as effective as intravenous," and the lag time was noted as 6.5 years.1 However, ganciclovir was initially marketed as an intravenous formulation, and the oral form was not available commercially until several years after initial marketing of the intravenous form.2,3 Thus, using only the availability of the intravenous form as the benchmark artificially inflates the period when assessment of the efficacy of both formulations could have been adequately conducted.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();